Clinical & Experimental Ophthalmology, ISSN 1442-6404, 05/2013, Volume 41, Issue 4, pp. 387 - 395
Journal Article
Clinical & Experimental Ophthalmology, ISSN 1442-6404, 05/2013, Volume 41, Issue 4, pp. 387 - 395
Background The objective of this study was to prospectively assess the risk of bleeding from vitreoretinal surgery in a continuous unbiased cohort of patients...
anti‐platelet agents | vitreoretinal surgery | anticoagulant | vitrectomy | scleral buckling | Vitreoretinal surgery | Vitrectomy | Anticoagulant | Scleral buckling | Anti-platelet agents | anti-platelet agents | HEMORRHAGE | WARFARIN | PREVENTION | OPHTHALMOLOGY | RISK | ASPIRIN | WITHDRAWAL | Blood Loss, Surgical - statistics & numerical data | Prospective Studies | Follow-Up Studies | Ticlopidine - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Vitreoretinal Surgery | Warfarin - adverse effects | Male | Postoperative Hemorrhage - chemically induced | Warfarin - therapeutic use | Aspirin - adverse effects | Ticlopidine - adverse effects | Aged, 80 and over | Adult | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Risk Factors | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Retinal Hemorrhage - chemically induced | Choroid Hemorrhage - chemically induced | Vitreous Hemorrhage - chemically induced | Aged | Eye Hemorrhage - chemically induced | Eye | Diabetic retinopathy | Care and treatment | Aspirin | Warfarin | Surgery | Anticoagulants | Drug therapy | Eye surgery
anti‐platelet agents | vitreoretinal surgery | anticoagulant | vitrectomy | scleral buckling | Vitreoretinal surgery | Vitrectomy | Anticoagulant | Scleral buckling | Anti-platelet agents | anti-platelet agents | HEMORRHAGE | WARFARIN | PREVENTION | OPHTHALMOLOGY | RISK | ASPIRIN | WITHDRAWAL | Blood Loss, Surgical - statistics & numerical data | Prospective Studies | Follow-Up Studies | Ticlopidine - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Vitreoretinal Surgery | Warfarin - adverse effects | Male | Postoperative Hemorrhage - chemically induced | Warfarin - therapeutic use | Aspirin - adverse effects | Ticlopidine - adverse effects | Aged, 80 and over | Adult | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Risk Factors | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Retinal Hemorrhage - chemically induced | Choroid Hemorrhage - chemically induced | Vitreous Hemorrhage - chemically induced | Aged | Eye Hemorrhage - chemically induced | Eye | Diabetic retinopathy | Care and treatment | Aspirin | Warfarin | Surgery | Anticoagulants | Drug therapy | Eye surgery
Journal Article
International Journal of STD & AIDS, ISSN 0956-4624, 10/2014, Volume 25, Issue 11, pp. 827 - 829
The incidence of cytomegalovirus retinitis has decreased significantly since the advent of antiretroviral therapy. However, it remains an important problem in...
Cytomegalovirus | treatment | HIV | retinitis | AIDS | ganciclovir | opportunistic infection | CMV | resistance | INFECTIOUS DISEASES | IMMUNOLOGY | MAINTENANCE THERAPY | PATIENT | PROGRESSION | Antiviral Agents - therapeutic use | Cytomegalovirus Retinitis - diagnosis | Humans | Middle Aged | AIDS-Related Opportunistic Infections - drug therapy | Salvage Therapy | Male | Treatment Outcome | Visual Acuity | Viral Load | Incidence | Cytomegalovirus Retinitis - drug therapy | HIV Infections - diagnosis | HIV Infections - drug therapy | Foscarnet - therapeutic use
Cytomegalovirus | treatment | HIV | retinitis | AIDS | ganciclovir | opportunistic infection | CMV | resistance | INFECTIOUS DISEASES | IMMUNOLOGY | MAINTENANCE THERAPY | PATIENT | PROGRESSION | Antiviral Agents - therapeutic use | Cytomegalovirus Retinitis - diagnosis | Humans | Middle Aged | AIDS-Related Opportunistic Infections - drug therapy | Salvage Therapy | Male | Treatment Outcome | Visual Acuity | Viral Load | Incidence | Cytomegalovirus Retinitis - drug therapy | HIV Infections - diagnosis | HIV Infections - drug therapy | Foscarnet - therapeutic use
Journal Article
International Journal of Oncology, ISSN 1019-6439, 07/2011, Volume 39, Issue 1, pp. 271 - 278
Vandetanib is a multi-targeted receptor tyrosine kinase inhibitor that is in clinical development for the treatment of solid tumours. This preclinical study...
Vandetanib | Lung cancer | VEGFR-2 | EGFR | Endothelial cells | Xenografts | XENOGRAFT MODELS | endothelial cells | xenografts | ZD6474 | lung cancer | CELL LUNG-CANCER | GROWTH-FACTOR RECEPTOR | PLUS DOCETAXEL | THERAPY | vandetanib | ONCOLOGY | RANDOMIZED PHASE-II | DOUBLE-BLIND | TYROSINE KINASE INHIBITOR | TUMOR-GROWTH
Vandetanib | Lung cancer | VEGFR-2 | EGFR | Endothelial cells | Xenografts | XENOGRAFT MODELS | endothelial cells | xenografts | ZD6474 | lung cancer | CELL LUNG-CANCER | GROWTH-FACTOR RECEPTOR | PLUS DOCETAXEL | THERAPY | vandetanib | ONCOLOGY | RANDOMIZED PHASE-II | DOUBLE-BLIND | TYROSINE KINASE INHIBITOR | TUMOR-GROWTH
Journal Article
British Journal of Ophthalmology, ISSN 0007-1161, 03/2001, Volume 85, Issue 3, pp. 281 - 286
BACKGROUND/AIMS Sympathetic ophthalmia (SO) is a classic example of autoimmune disease where human leucocyte antigen (HLA) genomic associations could provide...
KOYANAGI-HARADA DISEASE | RHEUMATOID-ARTHRITIS | GAMMA | GENES | UVEITIS | OPHTHALMOLOGY | HLA | ASSOCIATION | T-CELLS | Haplotypes | Ireland - ethnology | Ophthalmia, Sympathetic - ethnology | Severity of Illness Index | Genetic Predisposition to Disease - genetics | Humans | Male | Risk | HLA Antigens - genetics | United Kingdom - ethnology | Case-Control Studies | Polymorphism, Genetic | Phenotype | Ophthalmia, Sympathetic - genetics | Alleles | Polymerase Chain Reaction | Female | Genetic Predisposition to Disease - ethnology | Histocompatibility Testing - methods | Medical personnel | Antigens | Genotype & phenotype | Hospitals | Peptides | Pathogenesis | Lymphocytes | Genes | Surgery | Animal diseases | Autoimmune diseases | Deoxyribonucleic acid--DNA | Original articles - Clinical science
KOYANAGI-HARADA DISEASE | RHEUMATOID-ARTHRITIS | GAMMA | GENES | UVEITIS | OPHTHALMOLOGY | HLA | ASSOCIATION | T-CELLS | Haplotypes | Ireland - ethnology | Ophthalmia, Sympathetic - ethnology | Severity of Illness Index | Genetic Predisposition to Disease - genetics | Humans | Male | Risk | HLA Antigens - genetics | United Kingdom - ethnology | Case-Control Studies | Polymorphism, Genetic | Phenotype | Ophthalmia, Sympathetic - genetics | Alleles | Polymerase Chain Reaction | Female | Genetic Predisposition to Disease - ethnology | Histocompatibility Testing - methods | Medical personnel | Antigens | Genotype & phenotype | Hospitals | Peptides | Pathogenesis | Lymphocytes | Genes | Surgery | Animal diseases | Autoimmune diseases | Deoxyribonucleic acid--DNA | Original articles - Clinical science
Journal Article
International journal of oncology, 07/2011, Volume 39, Issue 1, p. 271
Vandetanib is a multi-targeted receptor tyrosine kinase inhibitor that is in clinical development for the treatment of solid tumours. This preclinical study...
Humans | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Mice, SCID | Xenograft Model Antitumor Assays | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Phenotype | Receptor, Epidermal Growth Factor - metabolism | Animals | Piperidines - pharmacology | Signal Transduction - drug effects | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Female | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Mice | Neoplasms - physiopathology | Quinazolines - pharmacology | Disease Models, Animal | Endothelial Cells - drug effects
Humans | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Mice, SCID | Xenograft Model Antitumor Assays | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Phenotype | Receptor, Epidermal Growth Factor - metabolism | Animals | Piperidines - pharmacology | Signal Transduction - drug effects | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Female | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Mice | Neoplasms - physiopathology | Quinazolines - pharmacology | Disease Models, Animal | Endothelial Cells - drug effects
Journal Article
Retina, ISSN 0275-004X, 1999, Volume 19, Issue 6, pp. 568 - 569
Eye Abnormalities - diagnosis | Eye - blood supply | Humans | Hyperplasia | Male | Eye Diseases - congenital | Retinal Detachment - surgery | Visual Acuity | Vitreous Body - abnormalities | Eye Abnormalities - surgery | Eye Diseases - diagnosis | Retinal Detachment - complications | Ophthalmic Artery - abnormalities | Eye - embryology | Retinal Detachment - diagnosis | Eye Diseases - surgery | Vitreous Body - blood supply | Vitreous Body - pathology | Female | Vitrectomy | Child | Fetal Blood | Eye Abnormalities - complications
Journal Article
BRITISH JOURNAL OF OPHTHALMOLOGY, ISSN 0007-1161, 07/1990, Volume 74, Issue 7, pp. 417 - 420
One of the complications of sickle cell anemia is retinopathy, which can cause dilation of the retinal veins, microaneurysms (a microscopic dilatation of a...
OPHTHALMOLOGY | Prognosis | Sickle cell anemia | Complications | Abnormalities | Blood vessels | Choroid | Neovascularization | Retinal diseases
OPHTHALMOLOGY | Prognosis | Sickle cell anemia | Complications | Abnormalities | Blood vessels | Choroid | Neovascularization | Retinal diseases
Journal Article
British Journal of Ophthalmology, ISSN 0007-1161, 10/1988, Volume 72, Issue 10, pp. 727 - 732
Serial retinal examinations were performed in children aged 5 years and older and fluorescein angiography/angioscopy in children 6 years and older...
Body Weight | Age Factors | Humans | Risk Factors | Hematocrit | Child, Preschool | Male | Visual Acuity | Retinal Diseases - epidemiology | Anemia, Sickle Cell - epidemiology | Adolescent | Female | Jamaica | Child | Fetal Hemoglobin - analysis | Hemoglobins - analysis | Cohort Studies | Fluorescein Angiography
Body Weight | Age Factors | Humans | Risk Factors | Hematocrit | Child, Preschool | Male | Visual Acuity | Retinal Diseases - epidemiology | Anemia, Sickle Cell - epidemiology | Adolescent | Female | Jamaica | Child | Fetal Hemoglobin - analysis | Hemoglobins - analysis | Cohort Studies | Fluorescein Angiography
Journal Article
British Journal of Ophthalmology, ISSN 0007-1161, 1991, Volume 75, Issue 10, pp. 639 - 639
Journal Article
British Journal of Ophthalmology, ISSN 0007-1161, 07/1990, Volume 74, Issue 7, pp. 417 - 420
Choroidal neovascularisation developed in 62/66 (94%) eyes followed up for a mean period of 11.2 years after treatment with xenon arc feeder vessel coagulation...
Anemia, Sickle Cell - surgery | Retinal Detachment - etiology | Anemia, Sickle Cell - complications | Humans | Middle Aged | Choroid - blood supply | Neovascularization, Pathologic | Male | Light Coagulation - adverse effects | Vitreous Hemorrhage - etiology | Adolescent | Adult | Female | Aged | Iatrogenic Disease | Vision Disorders - etiology
Anemia, Sickle Cell - surgery | Retinal Detachment - etiology | Anemia, Sickle Cell - complications | Humans | Middle Aged | Choroid - blood supply | Neovascularization, Pathologic | Male | Light Coagulation - adverse effects | Vitreous Hemorrhage - etiology | Adolescent | Adult | Female | Aged | Iatrogenic Disease | Vision Disorders - etiology
Journal Article
Archives of Ophthalmology, ISSN 0003-9950, 10/1996, Volume 114, Issue 10, p. 1294
Journal Article
Survey of Anesthesiology, ISSN 0039-6206, 06/1959, Volume 3, Issue 3, p. 285
Journal Article
Archives of Ophthalmology, ISSN 0003-9950, 10/1996, Volume 114, Issue 10, pp. 1294 - 1294
GENE | OPHTHALMOLOGY | Retinal Diseases - diagnosis | Humans | Male | Chromosome Disorders | von Hippel-Lindau Disease - genetics | Hemangioma - diagnosis | Chromosomes, Human, Pair 5 | von Hippel-Lindau Disease - diagnosis | Chromosomes, Human, Pair 3 | Chromosome Aberrations - genetics | Gene Deletion | Adult | Female | Mutation | Adenomatous Polyposis Coli - genetics | Fundus Oculi | Adenomatous Polyposis Coli - diagnosis
Journal Article
Archives of Ophthalmology, ISSN 0003-9950, 03/1991, Volume 109, Issue 3, pp. 363 - 367
• A randomized prospective clinical trial of argon laser scatter photocoagulation therapy for proliferative sickle cell retinopathy was performed on 116...
OCULAR COMPLICATIONS | DIAGNOSIS | HEMOGLOBINOPATHIES | MANAGEMENT | PHOTO-COAGULATION | DISEASE | OPHTHALMOLOGY | UPDATE | Hemoglobin SC Disease - complications | Prospective Studies | Follow-Up Studies | Retinal Neovascularization - surgery | Humans | Male | Light Coagulation - adverse effects | Visual Acuity | Vitreous Hemorrhage - surgery | Light Coagulation - methods | Retinal Diseases - etiology | Survival Analysis | Adult | Female | Scattering, Radiation | Retinal Diseases - surgery
OCULAR COMPLICATIONS | DIAGNOSIS | HEMOGLOBINOPATHIES | MANAGEMENT | PHOTO-COAGULATION | DISEASE | OPHTHALMOLOGY | UPDATE | Hemoglobin SC Disease - complications | Prospective Studies | Follow-Up Studies | Retinal Neovascularization - surgery | Humans | Male | Light Coagulation - adverse effects | Visual Acuity | Vitreous Hemorrhage - surgery | Light Coagulation - methods | Retinal Diseases - etiology | Survival Analysis | Adult | Female | Scattering, Radiation | Retinal Diseases - surgery
Journal Article
The Washington Post, Times Herald (1959-1973), 01/1968, p. A16
Newspaper Article
Journal for ImmunoTherapy of Cancer, ISSN 2051-1426, 11/2016, Volume 4, Issue S1
Journal Article
1963, v. 1-18 in 13. illus.
Book
Annals of Family Medicine, ISSN 1544-1709, 2011, Volume 9, Issue 1, pp. 3 - 11
Abstract Purpose We wanted to determine the impact of automated family history assessment and tailored messages for coronary heart disease, stroke, diabetes,...
Internal Medicine | Disease prevention | Risk assessment | Family history questionnaire | risk assessment | MEDICINE, GENERAL & INTERNAL | PUBLIC-HEALTH | GENETICS | family history questionnaire | INFORMATION | PRIMARY HEALTH CARE | RISK-ASSESSMENT | CANCER | Blood Pressure | Life Style | Cholesterol - blood | Humans | Middle Aged | Male | Chronic Disease - prevention & control | Exercise | Adult | Female | Aspirin - therapeutic use | Communication | Stroke - prevention & control | Ovarian Neoplasms - prevention & control | Risk Reduction Behavior | Health Promotion - methods | Risk Factors | Diabetes Mellitus, Type 2 - prevention & control | Blood Glucose | Health Behavior | Breast Neoplasms - prevention & control | Coronary Disease - prevention & control | Mass Screening | Diet | Internet | Program Evaluation | Smoking | Original Research
Internal Medicine | Disease prevention | Risk assessment | Family history questionnaire | risk assessment | MEDICINE, GENERAL & INTERNAL | PUBLIC-HEALTH | GENETICS | family history questionnaire | INFORMATION | PRIMARY HEALTH CARE | RISK-ASSESSMENT | CANCER | Blood Pressure | Life Style | Cholesterol - blood | Humans | Middle Aged | Male | Chronic Disease - prevention & control | Exercise | Adult | Female | Aspirin - therapeutic use | Communication | Stroke - prevention & control | Ovarian Neoplasms - prevention & control | Risk Reduction Behavior | Health Promotion - methods | Risk Factors | Diabetes Mellitus, Type 2 - prevention & control | Blood Glucose | Health Behavior | Breast Neoplasms - prevention & control | Coronary Disease - prevention & control | Mass Screening | Diet | Internet | Program Evaluation | Smoking | Original Research
Journal Article
The Washington Post, Times Herald (1959-1973), 07/1965, p. A20
Newspaper Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.